PMSA Journal
The Journal of the Pharmaceutical Management Science Association is the official research publication of the Pharmaceutical Management Science Association. Its purpose is to promote and embody the mission of the Pharmaceutical Management Science Association. In particular, the journal aims to help meet the following goals of the Association:
The key points in achieving this mission are:
- Raise awareness and promote use of Management Science in the pharmaceutical industry
- Foster sharing of ideas, challenges, and learning to increase overall level of knowledge and skill in this area
- Provide training opportunities to ensure continual growth within Pharmaceutical Management Science
- Encourage interaction and networking among peers in this area
The Journal is published in electronic format on the Association’s Web site. The Journal publishes manuscripts that advance knowledge across a wide range of practical issues in the application of techniques to solve Pharmaceutical Management Science problems, and that support the professional growth of Association members. Once per year, The Journal of the PMSA publishes a wide range of peer-reviewed practice papers, research articles and professional briefings written by industry experts and academics. Articles focus on the issues of key importance to pharmaceutical management science practitioners.
Please submit correspondence to:
Pharmaceutical Management Science Association
1024 Capital Center Drive, Suite 205
Frankfort, KY 40601
(877) 279-3422
PMSA Journal Abstracts Now Being Accepted
Get ready to showcase your research! We invite you to submit an abstract for a chance to feature your work in the upcoming issue of the PMSA Journal, to be published in Spring 2025. Don’t miss this exciting opportunity to share your insights with the community! Click here to read our submission guidelines.. — Abstracts are due by October 21, 2024.
Spring 2025
- Using Longitudinal Claims Data to Predict Response Uptake in Rare and Ultra-Rare Diseases
Jerry A. Rosenblatt, PhD – Rosenblatt Life Science Consultants; Adrian Ghenadenik, PhD – Rosenblatt Life Science Consultants; Rhys Rosenberg – Rosenblatt Life Science Consultants; Ashwin Anand – FORIAN Inc. - Measuring the Impact of Tech-Driven Specialty Pharmacy Collaboration
James Battaglia, Claritas Rx - Iterative Causal Segmentation: Filling the Gap between Market Segmentation and Marketing Strategy
Kaihua Ding, Jingsong Cui, Mohammad Soltani, and Jing Jin, AZ Brain, AstraZeneca PLC - Can Generative AI Help to Understand Patient Journeys More Efficiently and Effectively?
Gagan Bhatia, Roche/Genentech; Marco Giannitrapani, Roche; John Kaspar, Roche; Sharon Lee, Roche/Genentech; Suyash Mishra, Roche; and Jessica Tashker, Ph.D., Roche - Multimodal Multi-Agent Solution for Sales Representatives
Shihan He, Machine Learning Engineer at AI CoE, Novo Nordisk Inc.; and Anubhav Srivastav, Associate Director at AI CoE, Novo Nordisk Inc. - Unlocking Commercial Success with Multimodal LLMs: Approach and Comprehensive Validation Framework
Daniel Young, AstraZeneca; Atharv Sharma, ZS Associates; Arindam Paul, ZS Associates; Prashant Mishra, ZS Associates; Arrvind Sunder, ZS Associates - Using Machine Learning to Establish the Impact of Patient Support Services and the Coordinated Efforts of Field Reimbursement and Access Specialists on Therapy Fulfillment Rates, Time to Fulfillment, and Patient Adherence
Prabhjot Singh, Senior Director, Axtria Inc.; Hemant Kumar, Director, Axtria Inc.; Aayush Gupta, Manager, Axtria Inc. - Enhance your Insights by Leveraging Public Domain Data Sources
JP Tsang, PhD and MBA (INSEAD), President of Bayser Consulting; Shunmugam Mohan, VP of Operations, Bayser Consulting; Maylis Larroque, Senior Consultant, Bayser Consulting; Zhangjin Xu, PhD, Senior Consultant, Bayser Consulting - Looking Beyond Hype: Using AI to Drive Business Impact for Brand and Sales Leaders
Vineet Rathi, Principal, Axtria Inc.